This post is Part 3 in a series based on the Complion webinar, The Future of the Clinical Research Industry, as presented by John Neal, CEO of PCRS Network. In that webinar, John explores a variety of factors that are driving the evolution of clinical research.
Inefficient and ineffective. That’s how John Neal sums up his frank assessment of the current state of the clinical research site selection process. John bases that assessment on data available from CenterWatch and other sources. “Something on the order of 50% of all sites that are initiated across all studies don’t meet their original enrollment expectations,” John observes.